Inventor · disambiguated record
Clifford A. Lingwood
Also filed as: KROYANKER LEGAL REPRESENTATIVE · LINGWOOD CLIFFORD · LINGWOOD CLIFFORD A
18 granted patents·6 pending applications·153 citations·filing 1984–2015
94Inventor score
Files withHOSPITAL FOR SICK CHILDREN RES4HOSPITAL FOR SICK CHILDREN2HSC RES & DEV LTD PARTNERSHIP2HSC RES DEV CORP2HSC RES DEV LP2
Top patents by PatentIndex Score
24 records- 0188US4767720AAntidigoxin antibodiesHSC RES DEV CORP·Filed 1985·Granted Aug 30, 1988·44 cites·29 claims
- 0281US8252789B2Compositions and methods for treating lysosomal disordersLINGWOOD CLIFFORD A·Filed 2008·Granted Aug 28, 2012·5 cites·9 claims
- 0376US6835710B1Verotoxin pharmaceutical compositions and medical treatments therewithHSC RES & DEV LTD PARTNERSHIP·Filed 2000·Granted Dec 28, 2004·6 cites·5 claims
- 0470US7560426B2Verotoxin pharmaceutical compositions and medical treatments therewithHSC RES DEV LP·Filed 2007·Granted Jul 14, 2009·0 cites·8 claims
- 0569US4597999AMethod for coupling a hydrocarbon containing molecular speciesHOSPITAL FOR SICK CHILDREN·Filed 1984·Granted Jul 1, 1986·19 cites·15 claims
- 0668US9023845B2Compositions and methods for treating lysosomal disordersLINGWOOD CLIFFORD A·Filed 2012·Granted May 5, 2015·1 cites·19 claims
- 0766US7208468B2Verotoxin pharmaceutical compositions and medical treatments therewithONTARIO CANCER INST·Filed 2004·Granted Apr 24, 2007·0 cites·15 claims
- 0859US9901612B2Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteinsHOSPITAL FOR SICK CHILDREN·Filed 2014·Granted Feb 27, 2018·0 cites·6 claims
- 0957US2012052053A1Compositions and methods for the treatment of altered alpha-synuclein functionMANNING-BOG AMY B·Filed 2009·Application pending·0 cites
- 1055US7335750B2Hybrid compositions for intracellular targetingHOSPITAL FOR SICK CHILDREN RES·Filed 2002·Granted Feb 26, 2008·0 cites·14 claims
- 1151US6482586B1Hybrid compositions for intracellular targetingHOSPITAL FOR SICK CHILDREN RES·Filed 1997·Granted Nov 19, 2002·14 cites·9 claims
- 1251US5164298AVerocytotoxin receptor assayHSC RES DEV CORP·Filed 1988·Granted Nov 17, 1992·19 cites·39 claims
- 1350US5973128AGlycolipid mimics and methods of use thereofHOSPITAL FOR SICK CHILDREN RES·Filed 1996·Granted Oct 26, 1999·8 cites·5 claims
- 1449US5968894AVerotoxin pharmaceutical compositions and medical treatments therewithFiled 1995·Granted Oct 19, 1999·17 cites·12 claims
- 1549US2015044193A1COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED a-SYNUCLEIN FUNCTIONNEURALTUS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1645US5411948AUse of host cell phospholipids for inhibiting microbial colonizationHCS RESEARCH AND DEV·Filed 1993·Granted May 2, 1995·8 cites·12 claims
- 1745US2015202185A1Compositions and methods for treating lysosomal disordersNEURALTUS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1844US6228370B1Verotoxin pharmaceutical compositions and medical treatments therewithFiled 1997·Granted May 8, 2001·4 cites·9 claims
- 1944US2012201853A1Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteinsLINGWOOD CLIFFORD·Filed 2010·Application pending·0 cites
- 2037US6103883AGlycolipid mimics and methods of use thereofHSC RES DEV LP·Filed 1999·Granted Aug 15, 2000·3 cites·11 claims
- 2136US6218147B1Haemophilus adhesin proteinHSC RES & DEV LTD PARTNERSHIP·Filed 1999·Granted Apr 17, 2001·3 cites·9 claims
- 2235US2002099002A1Inhibition of angiogenesis by verotoxinsHOSPITAL FOR SICK CHILDREN RES·Filed 2001·Application pending·0 cites
- 2331US6054134AHaemophilus adhesin proteinHSC RESEARCH & DEV LIMITED·Filed 1996·Granted Apr 25, 2000·2 cites·12 claims
- 2430US2018179166A1Small molecule inhibitors of gp120-mediated hiv infection and methods of useVIROCARB INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Clifford A. Lingwood files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →